Psychosocial Intervention for Schizophrenia Prevention

This trial tests a family-based psychosocial intervention to determine its effectiveness in preventing schizophrenia in children and young adults. The intervention aims to reduce bothersome, psychotic-like experiences in individuals with a family history of severe mental illnesses. Participants must have two or more risk factors and remain psychiatrically stable without recent medication changes. The trial excludes those who have had psychotic disorders or are at high risk for them. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research that could shape future preventative strategies for schizophrenia.

The trial does not specify if you need to stop taking your current medications, but you must be psychiatrically stable and have had no major changes in antidepressant, stimulant, or antipsychotic medication in the past 4 weeks.

Previous studies have shown that treatments focusing on social and psychological support are safe for individuals with conditions like schizophrenia. Research indicates that these treatments do not raise the risk of crises or emergencies for participants. This suggests that participants generally handle the treatment well without harmful side effects.

Researchers are excited about psychosocial interventions for schizophrenia prevention because they offer a non-pharmacological approach to managing the condition. Unlike standard treatments that often involve antipsychotic medications, which can have significant side effects, psychosocial interventions focus on improving social skills, cognitive function, and emotional regulation. This treatment aims to address the root social and psychological challenges associated with schizophrenia, potentially offering a holistic way to prevent or reduce the onset of symptoms in at-risk individuals.

Research has shown that certain therapies can help people with schizophrenia by changing harmful thoughts and behaviors. Studies have found that these treatments effectively reduce symptoms and improve daily life. For example, cognitive behavioral therapy (CBT) addresses illogical thoughts and enhances thinking. These therapies also teach patients new skills to better manage their condition. Overall, they offer promising support in managing schizophrenia symptoms. Participants in this trial will receive a psychosocial intervention designed to prevent the onset of schizophrenia by addressing these factors.⁶⁷⁸⁹¹⁰